1. Introduction {#s0005}
===============

The optic radiation (OR) is an integral part of the afferent visual system and belongs to the most frequently affected white matter pathways in autoimmune neuroinflammatory disorders of the central nervous system, i.e. multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) ([@bb0020]; [@bb0025]; [@bb0030]; [@bb0050]; [@bb0130]; [@bb0145], [@bb0150]; [@bb0145], [@bb0150]; [@bb0155]; [@bb0160]; [@bb0190]; [@bb0195]; [@bb0215]; [@bb0280]). Diffusion-weighted magnetic resonance imaging (DW-MRI) yields the potential to non-invasively investigate microstructural OR integrity ([@bb0010]; [@bb0045]).

A multitude of DW-MRI post-processing techniques have been used in recent studies to investigate OR damage in neuroinflammatory disorders ([@bb0065]). TBSS is a widely used fully automated method to perform whole brain tract diffusion tensor imaging (DTI) analyses. ConTrack (CON-PROB) ([@bb0200], [@bb0205]) and CSD-based probabilistic tractography (CSD-PROB) ([@bb0120]; [@bb0125]; [@bb0250]) provide high sensitivity to delineate tracts through crossing fiber regions ([@bb0015]), facilitate the selection of pathways that connect two regions ([@bb0205]) and allow subsequent in-depth analysis, for example tract profiling, by calculating DTI values at different nodes along the OR. However, implementation of probabilistic tractography algorithms in the individual patient is frequently more time consuming due to manual predefinition of seed and target regions as well as manual or semi-automated cleaning of tractography results. Moreoever, accurate OR delineation in vivo is hampered by its complex structure with the sharp bending in the Meyer\'s loop ([@bb0125]), the reduced fiber densitiy in this area compared to the body of the OR ([@bb0120]; [@bb0285]) and the presence of crossing fibers along the pathway ([@bb0205]).

Previous investigations using CON-PROB found OR DTI metrics to be altered in long-standing MS patients compared to healthy controls with correlations between OR FA and OR T2 lesion volume ([@bb0100]). A study investigating clinically isolated ON patients with CON-PROB found reduced fractional anisotropy (FA) and elevated radial diffusivity (RD) to be associated with OR lesions. No correlation between OR DTI and retinal nerve fiber layer thickness (RNFL) measured by optical coherence tomography (OCT) was found ([@bb0170]). By contrast, investigations using TBSS in MS patients with and without prior ON found strong correlations between RNFL and FA within the OR, suggesting trans-synaptic neurodegeneration after ON to explain the link between low RNFL thickness and low FA values in the OR ([@bb0190]). These contradictory results fall in line with previous studies either favoring ([@bb0140]; [@bb0145], [@bb0150]; [@bb0175]; [@bb0180]) or disfavoring ([@bb0040]) evidence on trans-neuronal changes in neuroinflammatory disorders. The conflicting diversity of published DTI studies might be partially owing to cohort inhomogeneities with regards to time from disease onset, severity of structural damage and clinical deficit as well as total and region-specific lesion load. Beyond this, the heterogeneous usage of different DTI post-processing techniques and their specific inherent limitations may account for inconsistent reports.

Validation studies of sensitivity, specificity and technical advantages and disadvantages of different DTI post-processing methods are thus highly required. Unfortunately, there is no "gold-standard" for non-invasive DTI-based OR tract-probing ([@bb0120]; [@bb0235]), making comparability between methods and validation of techniques difficult. To overcome these limitations, different methods need to be compared against each other under one specific research question.

The purpose of our study was to compare distinct TBSS-based and probabilistic tractography-based approaches in the delineation of OR and the detection of OR damage. We therefore investigated OR damage with different severity levels and compared a) NMOSD patients with prior ON with suspected severe OR damage, b) clinically isolated syndrome (CIS) and early relapsing-remitting multiple sclerosis (RRMS) patients with ON and suspected moderate OR damage and c) CIS and early RRMS patients without prior ON and potential OR damage against healthy controls (HCs). We evaluated inter-method agreement of FA values and compared the capacity of all methods to detect OR FA differences in all patient cohorts compared to HCs.

2. Material and methods {#s0010}
=======================

2.1. Subjects {#s0015}
-------------

Sixty-two patients were retrospectively analyzed from our research database. This included CIS and early RRMS with ON (CIS/RRMS-ON), CIS and early RRMS without ON (CIS/RRMS-NON), NMOSD with ON (NMOSD-ON) as well as 26 HCs (see [Table 1](#t0005){ref-type="table"}). All patients were examined under supervision of a board-certified neurologist at the NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin between January 2011 and July 2015.Table 1Study cohort description.Table 1HCCIS/RRMS-NONCIS/RRMS-ONNMOSD-ONSubjects \[n\]26211823Sex \[f(m)\]22(4)11(10)11(7)20(3)Age \[years; mean ± SD\]43.7 ± 15.733.4 ± 8.631.2 ± 7.746.7 ± 14.5Disease duration \[months; mean ± SD\]*n.a.*5.40 ± 6.674.63 ± 5.1594.17 ± 95.72EDSS \[median; range\]*n.a.*1.5 (0--4.0)1.5 (0--3.5)4.0 (0--6.5)RRMS diagnosis \[n\]*n.a.*5 (23.8%)3 (16.7%)*n.a.*AQP4-ab-positive \[n\]*n.a.n.a.n.a.*19History of bilateral optic neuritis*n.a.n.a.*04[^3]

We included 18 CIS/RRMS-ON patients from at the time of analysis 110 participants of the Berlin CIS Cohort study ([ClinicalTrials.gov](http://ClinicalTrials.gov){#ir0005} Identifier: [NCT01371071](ctgov:NCT01371071){#ir0010}; EA1/182/10). CIS/RRMS-ON patients were investigated following a first-time ON attack after 4.61 ± 5.51 months on average (range: 1--24 months) and showed no other neurological symptoms than ON-related visual dysfunction. All CIS/RRMS-ON patients presented with unilateral optic neuritis as their first clinical symptom. At the time of MRI examination, 3 of these patients fulfilled the 2010 revised McDonald criteria for MS ([@bb0165]) while the other 15 patients had a CIS. Twenty-one CIS/RRMS-NON patients from the same study were diagnosed as CIS (n = 16) or early RRMS (n = 5) according to the 2010 revised McDonald criteria and had a history of only one neurological attack distinct from ON (e.g. myelitis). Additionally, 23 patients meeting the international consensus diagnostic criteria for NMOSD ([@bb0280]) (19 Aquaporin-4-antibody-positive: 82.6%) ([@bb0080]; [@bb0135]; [@bb0305]) with a clinically definitive episode of at least one ON (NMOSD-ON) were included from at the time of analysis 53 patients of our neuromyelitis optica observational study (EA1/041/14). NMOSD-ON patients had a time lapse from last ON of 73.2 ± 87.1 months (range: 5--404 months). We enrolled 26 HCs from our imaging research database. Patients were excluded if they 1) were outside age range of 18--70, 2) suffered from ophthalmological defects other than ON, 3) had a history of neurological diseases distinct from MS or NMOSD, 4) had no available DTI acquisition. Further exclusion criteria were similar to general exclusion criteria valid for MRI at 3 T. Part of NMOSD-ON patients\' and HCs\' DTI data have been investigated and published in a previous study ([@bb0140]). All participants provided written informed consent prior to their inclusion in the study. The study was approved by the local ethics committee and was performed in accordance with the 1964 Declaration of Helsinki in its currently applicable version.

2.2. MRI acquisition and analysis {#s0020}
---------------------------------

All MRI data were acquired on the same 3 T scanner (Tim Trio Siemens, Erlangen, Germany) using a single-shot echo planar imaging DTI sequence (TR/TE = 7500/86 ms; FOV = 240 × 240 mm^2^; matrix 96 × 96, 61 slices no gap, slice thickness 2.3 mm, 64 non-colinear directions, b-value = 1000 s/mm^2^), a volumetric high-resolution T1 weighted magnetization prepared rapid acquisition gradient echo (MPRAGE) sequence (TR/TE/TI = 1900/2.55/900 ms, FOV = 240 × 240 mm^2^, matrix 240 × 240, 176 slices, slice thickness 1 mm) as well as a volumetric high-resolution fluid-attenuated inversion recovery sequence (3D FLAIR) (TR/TE/TI = 6000/388/2100 ms; FOV = 256 × 256 mm^2^, slice thickness 1.0 mm). 3D FLAIR images of all patients were checked and verified for total lesion volume and OR-specific lesion volume by three expert raters under the supervision of a board-certified radiologist. Whole-brain segmentation and quantification of lesions of FLAIR images were performed using ITK-SNAP ([www.itksnap.org](http://www.itksnap.org){#ir0015}) ([@bb0300]).

2.3. Image processing {#s0025}
---------------------

### 2.3.1. Tract-based spatial statistics analysis (TBSS) {#s0030}

DTI data analysis was carried out using TBSS ([@bb0230]) with tools from the FMRIB Software Library (FSL 5.0.9).

First, eddy-current and motion correction were run in FSL, then FA images were created by fitting a tensor model to the raw diffusion data using a least-squares algorithm in FDT, and then brain-extracted using BET ([@bb0220]). FA data were then aligned into a common space using the nonlinear registration tool FNIRT which uses a b-spline representation of the registration warp field. Next, the mean FA image was created and thinned to produce a mean FA skeleton that represents the centres of all tracts common to the group. Each subject\'s aligned FA data was then projected onto this skeleton ([Supplemental Fig. S1](#f0030){ref-type="graphic"}A and B; see Supplemental material for further method description).

TBSS skeleton masks were overlaid with two different atlas masks: (A) OR ROIs derived from the Juelich 1 mm probabilistic atlas optic radiation ROI thresholded to exclude the lowest 10% (JUEL-TBSS) and (B) Johns Hopkins University 1 mm white matter tractography probabilistic atlas\' posterior thalamic radiation ROI (JHU-TBSS) ([@bb0070]; [@bb0270]).

### 2.3.2. ConTrack probabilistic tractography and Vistalab tract profiling {#s0035}

DTI data analysis was performed using the open-source mrVista package (<http://vistalab.stanford.edu/software>). Probabilistic fiber tracking was performed using the Contrack algorithm (CON-PROB) ([@bb0200], [@bb0205]), designed to identify the most likely pathway between two ROIs. Prior to tractography, Eddy current-induced distortion correction and motion correction were performed in all subjects within the vistalab framework. The schematic diagram is shown in [Supplemental Fig. S1](#f0030){ref-type="graphic"}C (see also Supplemental material for pipeline details). Fiber tensors were fitted using a least-squares algorithm. The eigenvalue decomposition of the diffusion tensors was computed and FA measures were derived along the OR bundles, at 50 equally-spaced positions, resulting in an FA tract profile ([@bb0170]). Measurements were calculated by taking a weighted average of the measurements of each individual fiber at the node (so called "fiber core") ([@bb0290]) to combine measures throughout the length of the fibers across different subjects.

### 2.3.3. CSD-based probabilistic tractography and Vistalab tract profiling {#s0040}

We applied a combination of previously published OR tractography based on high order fiber orientation distributions estimated with CSD (CSD-PROB) ([@bb0120]; [@bb0125]) and weighted mean diffusivity calculation as well as tract profiling performance in Vistalab ([@bb0290]). Probabilistic tractography from seed to target masks was performed in each hemisphere using the MRtrix3 package ([http://www.mrtrix.org/](http://www.mrtrix.org/)){#ir0030}) ([@bb0245], [@bb0250], [@bb0255]). First, diffusion image preprocessing was performed, including eddy current-induced distortion correction and inter-volume subject motion correction by the use of MRtrix3-in-built usage of FSL\'s eddy tool ([@bb0005]; [@bb0225]).

Maps of the fiber orientation distributions (FODs) were calculated using CSD with a maximum harmonic order of 6 (CSD algorithm). OR reconstruction pipeline was modified after Martínez-Heras et al. and Lim et al. ([@bb0120]; [@bb0125]) with non-linear transformation of atlas ROIs in MNI space to individual T1 space using FSL FNIRT ([@bb0225]) and subsequent registration of ROIs from individual T1 space to individual DWI space using FSL FLIRT ([@bb0085]). The tensors were fitted using a linear least squares approach. The schematic diagram of the pipeline is presented in [Supplemental Fig. S1](#f0030){ref-type="graphic"}D (see also Supplemental material for pipeline details). We then used the resulting fibers to transfer them into the Vistalab environment and compute tract profiling and weighted mean FA of each tract modified after the procedure outlined in the CON-PROB and Vistalab profiling section.

2.4. Optical coherence tomography and visual acuity assessment {#s0045}
--------------------------------------------------------------

Optical coherence tomography (OCT) investigations were performed in all CIS/RRMS-NON patients, in 17 out of 18 CIS/RRMS-ON patients, in 22 out of 23 NMOSD-ON patients and in 21 out of 26 HC using a Heidelberg Engineering Spectralis spectral domain OCT (Heidelberg Engineering, Heidelberg, Germany) with automatic real-time (ART) function for image averaging. The peripapillary retinal nerve fiber layer (pRNFL) was measured with activated eye tracker using 3.4-mm ring scans around the optic nerve head (12°, 1536 A-scans 16 ≤ ART ≤ 100). Segmentation of global RNFL was performed semiautomatically using software provided by the OCT manufacturer (Eye Explorer 1.9.10.0 with viewing module 6.0.9.0; Heidelberg Engineering). Visual acuity tests were performed by either using ETDRS charts or the Traditional Snellen Eye Chart in all CIS/RRMS-NON, in 17 out of 18 CIS/RRMS-ON patients, in 21 out of 23 NMOSD-ON patients and in 21 out of 26 HC. Visual testing outcomes were converted in decimals.

2.5. Statistical analysis {#s0050}
-------------------------

For statistical analysis we used Graphpad Prism 6.0 (Graphpad Software, San Diego, CA, USA) software and R version 3.1.2 with packages psych, geepack, irr, ICC, lme4, [ROCt]{.ul} and ggplot. For comparison and correlation of absolute FA values between methods we used separate FA values of left and right OR and conducted a two-way repeated measures ANOVA to account for the effect of 1) method choice and 2) OR side on FA values within each patient group and an intraclass correlation coefficient (ICC) analysis. Agreement of FA values between methods was evaluated by Pearson\'s correlation coefficient analysis and Bland-Altman plots (BA-analysis within Graphpad Prism 6.0).

Exploratory comparisons of patient groups regarding T2 lesion volume, RNFL and visual acuity of worse eye were conducted using one-way ANOVA. For group comparisons and correlation analyses with clinical data, we combined FA measures of left and right optic radiation and calculated the simple mean of both values in JHU-TBSS, JUEL-TBSS and CON-PROB. Since OR volumes differed between right and left side in CSD-PROB, we used weighted mean of both values for CSD-PROB based group comparison and correlation analyses. Comparisons of patient groups regarding FA values were assessed using linear model analyses to account for FA values with subsequent R^2^ effect size measures estimation. A receiver operating characteristic (ROC) analysis was used to assess sensitivity and specificity of methods to discriminate each patient group from healthy controls corrected for age. Comparison of tract profiles was conduected using two-way ANOVA comparing FA values of patient groups in every node against HC group. Correction for multiple comparison was performed using Bonferroni correction. Correlations between OR FA values and OR T2 lesion volume, RNFL and visual acuity were performed using linear model analysis. For all statistical analyses, a p-value of \<0.05 was regarded as significant. Data are presented as mean ± SD, except for tract profling results that are displayed in mean ± standard error of the mean (SEM).

3. Results {#s0055}
==========

3.1. Method comparison {#s0060}
----------------------

### 3.1.1. Image processing quality {#s0065}

All four methods successfully generated visually appropriate OR tracts, with the exception of one subject in the CIS/RRMS-ON group using the CSD-PROB method.

### 3.1.2. Coefficient of variation in healthy controls {#s0070}

Coefficient of variation in HC group was lowest in JUEL-TBSS (3.99%) and highest in CON-PROB (13.54%) with comparable coefficients of variation in JHU-TBSS (5.88%) and CSD-PROB (7.21%).Table 2ICC analysis results of method comparisons by patient group.Table 2All patientsHCCIS/RRMS-NONCIS/RRMS-ONNMOSD-ONAll methods[a](#tf0010){ref-type="table-fn"}0.155[⁎](#tf0005){ref-type="table-fn"}0.0240.208[⁎](#tf0005){ref-type="table-fn"}0.252[⁎](#tf0005){ref-type="table-fn"}0.074[⁎](#tf0005){ref-type="table-fn"}JUEL-TBSS vs. JHU-TBSS0.3890.2150.3910.3500.527JUEL-TBSS vs. CON-PROB0.129[⁎](#tf0005){ref-type="table-fn"}−0.0840.236[⁎](#tf0005){ref-type="table-fn"}0.300[⁎](#tf0005){ref-type="table-fn"}−0.006JUEL-TBSS vs. CSD-PROB0.1400.0480.1750.1620.100JHU-TBSS vs. CON-PROB0.1220.0040.2050.260−0.003JHU-TBSS vs. CSD-PROB0.432[⁎](#tf0005){ref-type="table-fn"}0.232[⁎](#tf0005){ref-type="table-fn"}0.447[⁎](#tf0005){ref-type="table-fn"}0.578[⁎](#tf0005){ref-type="table-fn"}0.246[⁎](#tf0005){ref-type="table-fn"}CON-PROB vs. CSD-PROB0.165−0.0140.0850.1550.061[^4][^5][^6]Table 3Pearson correlation analysis between all methods by patient groups.Table 3All patientsHCCIS/RRMS-NONCIS/RRMS-ONNMOSD-ONPearson\'s *r*p-ValuePearson\'s *r*p-ValuePearson\'s *r*p-ValuePearson\'s *r*p-ValuePearson\'s *r*p-ValueJUEL-TBSS vs. JHU-TBSS0.8714\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.8076\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.8523\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.8683\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.9272\<0.0001[⁎](#tf5000){ref-type="table-fn"}JUEL-TBSS vs. CON-PROB0.27300.0003[⁎](#tf5000){ref-type="table-fn"}−0.21880.11910.49670.0008[⁎](#tf5000){ref-type="table-fn"}0.60020.0001[⁎](#tf5000){ref-type="table-fn"}−0.01510.9207JUEL-TBSS vs. CSD-PROB0.4186\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.27070.05230.45430.0025[⁎](#tf5000){ref-type="table-fn"}0.60940.0002[⁎](#tf5000){ref-type="table-fn"}0.26140.0864JHU-TBSS vs. CON-PROB0.3508\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.01640.90840.44940.0028[⁎](#tf5000){ref-type="table-fn"}0.7063\<0.0001[⁎](#tf5000){ref-type="table-fn"}−0.01190.9372JHU-TBSS vs. CSD-PROB0.4883\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.29400.0344[⁎](#tf5000){ref-type="table-fn"}0.51340.0005[⁎](#tf5000){ref-type="table-fn"}0.6428\<0.0001[⁎](#tf5000){ref-type="table-fn"}0.28360.0621CON-PROB vs. CSD-PROB0.22700.003[⁎](#tf5000){ref-type="table-fn"}−0.06290.65760.15090.33980.54230.0013[⁎](#tf5000){ref-type="table-fn"}0.26950.0769[^7][^8]Table 4Bias and limits of agreement of Bland-Altman analysis.Table 4Estimation of bias95% Limits of agreement (LOA)BiasSD of biasFromToJUEL-TBSS vs. JHU-TBSS0.04660.02060.00630.0871JUEL-TBSS vs. CON-PROB0.02180.0728−0.12090.1646JUEL-TBSS vs. CSD-PROB−0.06640.0452−0.15500.0221JHU-TBSS vs. CON-PROB0.09220.0612−0.02790.2123JHU-TBSS vs. CSD-PROB−0.01980.0453−0.10850.0689CSD-PROB vs. CON-PROB0.11210.0708−0.02660.2508[^9]Fig. 2Correlation of all FA values regarding each method.Correlation of all OR FA values assessing **A** JUEL-TBSS vs. JHU-TBSS, **B** JUEL-TBSS vs. CON-PROB, **C** JUEL-TBSS vs. CSD-PROB, **D** JHU-TBSS vs. CON-PROB, **E** JHU-TBSS vs. CSD-PROB, **F** CON-PROB vs. CSD-PROB.JUEL-TBSS = Juelich-based atlas ROI TBSS approach; JHU-TBSS = Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB = ConTrack-based probabilistic tractography. CSD-PROB = constrained spherical deconvolution based probabilistic tractography. TBSS = tract-based spatial statistics; OR = optic radiation.Fig. 2Fig. 1Absolute FA values of different DTI post-processing methods.Optic radiation FA values are shown for **A** healthy controls (HC), **B** CIS patients without prior optic neuritis, **C** CIS patients with optic neuritis in their medical history and **D** NMOSD-ON patients. Comparison of FA distribution yielded significant differences between all methods except for the comparison of JHU-TBSS and CSD-PROB in CIS/RRMS-NON, CIS/RRMS-ON and NMOSD-ON patients.JUEL-TBSS = Juelich-based atlas ROI TBSS approach; JHU-TBSS = Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB = ConTrack-based probabilistic tractography. CSD-PROB = constrained spherical deconvolution based probabilistic tractography. TBSS = tract-based spatial statistics.Fig. 1

### 3.1.3. Comparison of FA values between methods {#s0075}

Absolute FA value distribution of the different methods for ORs of both sides within each subject group are shown in [Fig. 1](#f0005){ref-type="fig"} (separate left and right OR FA values are shown in [Fig. S2](#f0035){ref-type="graphic"}). Two-way repeated measures ANOVA revealed a significant impact of 1) method choice and 2) OR side on FA values (see supplementary material, Table S1). Post-hoc tests with Bonferroni correction revealed significant differences between all methods except for the comparison of JHU-TBSS and CSD-PROB in CIS/RRMS-NON, CIS/RRMS-ON and NMOSD-ON. ICC analysis of absolute agreement of all FA values between methods showed poor agreement between methods with ICC values ranging from 0.112 to 0.432 (see [Table 2](#t0010){ref-type="table"}). Lower ICC values were found in patient groups with no suspected visual system damage (HC) and in NMOSD-ON with highest suspected OR damage whereas higher ICC agreement was found in patient groups with suspected moderate damage (CIS/RRMS-ON and CIS/RRMS-NON-group).

### 3.1.4. Inter-method agreement of FA values {#s0080}

Pearson correlation analysis revealed significant correlations when analyzing all methods against each other with Pearson\'s *r* ranging from 0.2730 (JUEL-TBSS vs. CON-PROB) to 0.8714 (JUEL-TBSS vs. JHU-TBSS; see [Table 3](#t0015){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. S3](#f0040){ref-type="graphic"}).

Bland-Altman plots showed good agreement between all methods with most FA values ranging within the 95% confidence interval from average of differences. Best limits of agreement (LOA) were observed between values of both TBSS-based approaches (LOA distance: 0.0934; see [Supplemental Fig. S4](#f0045){ref-type="graphic"}A; [Table 4](#t0020){ref-type="table"}). Comparison of probabilistic tractography based methods with TBSS based methods generally showed a proportional error with overestimation of high FA values and underestimation of low FA values in probabilistic tractography ([Fig. S4](#f0045){ref-type="graphic"}C and E). Best agreement of relative and absolute FA values between all methods were seen at medium FA values (0.45--0.5) suggesting good agreement in methods in identifying minimal to medium damage.

3.2. Comparison of patient groups against healthy controls {#s0085}
----------------------------------------------------------

### 3.2.1. Patient group differences from HC and effect size {#s0090}

Comparison of patient groups against healthy controls regarding T2 lesion volume, OCT RNFL, visual acuity and optic radiation FA values are shown in [Table 5](#t0025){ref-type="table"}. All patient groups showed higher T2 lesion volume and increased OR specific T2 lesion volume compared to HC. RNFL was significantly decreased compared to HC in CIS/RRMS-ON and NMOSD-ON, while visual impairment was only seen in NMOSD-ON group. Linear model analysis of FA differences between each patient group and healthy controls showed FA differences between NMOSD-ON and HCs throughout all methodologies (JUEL-TBSS: p = 0.0043; JHU-TBSS: p = 0.0002; CON-PROB: p = 0.0024; CSD-PROB: p \< 0.0001; [Fig. 3](#f0015){ref-type="fig"}). p-Values and R^2^ as the effect size and proportion of variance explained by the method are displayed in [Table 6](#t0030){ref-type="table"}. Highest effect size in the discrimination of HC and NMOSD was seen in CSD-PROB (R^2^ = 0.282). CSD-PROB revealed significant FA differences between CIS/RRMS-ON patients and HCs, that were not observable when other methods were applied.Table 5Comparison of patient groups against healthy controls regarding T2 lesion volume, visual parameters and optic radiation FA values.Table 5HCCIS/RRMS-NONCIS/RRMS-ONNMOSD-ONANOVA pTotal T2 lesion volume \[ml; mean ± sd\]0.38 ± 0.662.87[⁎](#tf0015){ref-type="table-fn"} ± 4.392.59[⁎](#tf0015){ref-type="table-fn"} ± 3.172.15[⁎](#tf0015){ref-type="table-fn"} ± 3.070.084OR-specific T2 lesion volume \[ml; mean ± sd\]0.04 ± 0.070.70[⁎](#tf0015){ref-type="table-fn"} ± 1.020.57[⁎](#tf0015){ref-type="table-fn"} ± 0.700.44[⁎](#tf0015){ref-type="table-fn"} ± 0.870.017[⁎](#tf0015){ref-type="table-fn"}RNFL \[μm; mean ± sd\]96.90 ± 7.5098.21 ± 12.1687.92[⁎](#tf0015){ref-type="table-fn"} ± 14.7667.12[⁎](#tf0015){ref-type="table-fn"} ± 19.72\<0.001[⁎](#tf0015){ref-type="table-fn"}Visual acuity of worse eye \[mean ± sd\]1.02 ± 0.311.00 ± 0.370.96 ± 0.290.74[⁎](#tf0015){ref-type="table-fn"} ± 0.470.003[⁎](#tf0015){ref-type="table-fn"}FA \[JUEL-TBSS\]0.46 ± 0.020.46 ± 0.020.46 ± 0.020.44[⁎](#tf0015){ref-type="table-fn"} ± 0.030.012[⁎](#tf0015){ref-type="table-fn"}FA \[JHU-TBSS\]0.52 ± 0.030.50 ± 0.040.51 ± 0.040.48[⁎](#tf0015){ref-type="table-fn"} ± 0.040.004[⁎](#tf0015){ref-type="table-fn"}FA \[CON-PROB\]0.42 ± 0.060.43 ± 0.070.42 ± 0.060.38[⁎](#tf0015){ref-type="table-fn"} ± 0.060.010[⁎](#tf0015){ref-type="table-fn"}FA \[CSD-PROB\]0.54 ± 0.030.52[⁎](#tf0015){ref-type="table-fn"} ± 0.040.53 ± 0.030.50[⁎](#tf0015){ref-type="table-fn"} ± 0.040.001[⁎](#tf0015){ref-type="table-fn"}[^10][^11][^12]Fig. 3OR mean FA comparison of patient groups and HCs arranged by methods.Mean FA distribution of individual TBSS skeletons within JUEL-TBSS (**A**) and JHU-TBSS (**B**). Both approaches show significant differences between HC and NMOSD group. JHU also shows significant differences between NMOSD and all CIS groups and differences between HC and CIS and HC and CIS/RRMS-NON. Comparison of weighted mean FA distribution within CON-PROB tracts (**C**) and CSD-PROB OR fibers (**D**) reveal similar significant differences between HC and NMOSD and NMOSD with all CIS/RRMS-subgroups. CSD-PROB also reveals significant differences between HC and all CIS-subgroups.FA = fractional anisotropy; HC = healthy controls; OR = optic radiation; TBSS = tract-based spatial statistics; JHU = Johns Hopkins University; ROI = region of interest; CSD = constrained spherical deconvolution; NMOSD = neuromyelitis optica spectrum disorder.\* p \< 0.05; \*\* p \< 0.005; \*\*\* p \< 0.0005; \*\*\*\* p \< 0.0001.Fig. 3Table 6FA differences between patient groups and healthy controls.Table 6CIS/RRMS-NON vs. HCCIS/RRMS-ON vs. HCNMOSD-ON vs. HCp-ValueR^2^p-ValueR^2^p-ValueR^2^JUEL-TBSS0.6610.0040.6280.0050.004[⁎](#tf6000){ref-type="table-fn"}0.161JHU-TBSS0.1340.0490.3620.020\<0.001[⁎](#tf6000){ref-type="table-fn"}0.262CON-PROB0.6630.0040.8180.0010.002[⁎](#tf6000){ref-type="table-fn"}0.179CSD-PROB0.035[⁎](#tf6000){ref-type="table-fn"}0.0940.2980.026\<0.001[⁎](#tf6000){ref-type="table-fn"}0.282[^13][^14]

### 3.2.2. ROC-analysis {#s0095}

AUC values to discriminate HCs from NMOSD-ON were highest in CSD-PROB (AUC = 0.812), while slightly lower in CON-PROB (AUC = 0.742), JHU-TBSS (AUC = 0.756) and JUEL-TBSS (AUC = 0.719; [Fig. 4](#f0020){ref-type="fig"}). ROC-analysis results of comparison between HC vs. CIS/RRMS-ON and HC vs. CIS/RRMS-NON are shown in [Table 7](#t0035){ref-type="table"}.Fig. 4ROC curves and AUCs for TBSS and CSD-based analysis methods.ROC curves and AUCs are displayed comparing HC with NMOSD corrected for age by use of **A** JUEL-TBSS, **B** JHU-TBSS, **C** CON-PROB and **D** CSD-PROB.ROC = receiver operating characteristics; AUC = area under the curve; HC = healthy controls; NMOSD = neuromyelitis optica spectrum disorder; TBSS = tract-based spatial statistics; CSD = constrained spherical deconvolution; JHU = Johns Hopkins University.Fig. 4Table 7AUC values for the comparison of patient groups against healthy controls by each method corrected for age.Table 7MethodGroup 1Group 2AUCJUEL-TBSSHCCIS/RRMS-NON0.611JUEL-TBSSHCCIS/RRMS-ON0.625JUEL-TBSSHCNMOSD-ON0.719JHU-TBSSHCCIS/RRMS-NON0.743JHU-TBSSHCCIS/RRMS-ON0.704JHU-TBSSHCNMOSD-ON0.756CON-PROBHCCIS/RRMS-NON0.704CON-PROBHCCIS/RRMS-ON0.523CON-PROBHCNMOSD-ON0.742CSD-PROBHCCIS/RRMS-NON0.796CSD-PROBHCCIS/RRMS-ON0.626CSD-PROBHCNMOSD-ON0.812[^15]

### 3.2.3. Tract profiling -- subject group comparison {#s0100}

Tract profiles comparing patient groups are shown in [Fig. 5](#f0025){ref-type="fig"}. Significant differences between NMOSD-were seen in both methods (CON-PROB: nodes 26--47; CSD-PROB: nodes 20--25 and 48--50; [Fig. 5](#f0025){ref-type="fig"}).Fig. 5Tract profiles of the optic radiation in different patient groups.OR partitioning into 50 equally divided nodes in NMOSD (red), CIS/RRMS-ON (orange) and CIS/RRMS-NON (yellow) patients and Healthy controls (green) using (**A**) Contrack-based probabilistic tractography (**B**) CSD-based tractography.OR = optic radiation; CIS = clinically isolated syndrome; ON = optic neuritis; CSD = constrained spherical deconvolution; NMOSD = neuromyelitis optica spectrum disorder; FA = fractional anisotropy.Fig. 5

### 3.2.4. OR-specific lesions and OR FA {#s0105}

We investigated possible correlations between OR FA values and optic radiation specific lesion volume. JUEL-TBSS, JHU-TBSS and CSD-PROB showed significant correlations between FA and OR T2 lesion volume in the CIS/RRMS-NON group (see [Table 8](#t0040){ref-type="table"}).Table 8Correlations of optic radiation specific lesion volume, RNFL and visual acuity with optic radiation FA values by method.Table 8JUEL-TBSSJHU-TBSSCON-PROBCSD-PROBEstimateStd errorp-ValueEstimateStd errorp-ValueEstimateStd errorp-ValueEstimateStd errorp-ValueOR T2 Lesion volumeHC−0.0730.0600.23−0.1240.0890.170.1520.1420.290.0260.1080.24CIS/RRMS-NON−0.0220.005**\<0.01**[⁎](#tf7000){ref-type="table-fn"}−0.0440.008**\<0.01**[⁎](#tf7000){ref-type="table-fn"}−0.0220.0170.21−0.0310.012**0.01**[⁎](#tf7000){ref-type="table-fn"}CIS/RRMS-ON−0.0110.0090.26−0.0220.0150.15−0.0140.0230.54−0.0270.0140.06NMOSD-ON−0.0100.0070.18−0.0130.0080.15−0.0160.0110.15−0.0030.0090.76  RNFLHC0.0010.0000.570.0010.0000.980.0010.0000.370.0010.0000.21CIS/RRMS-NON0.0010.000**\<0.01**[⁎](#tf7000){ref-type="table-fn"}0.0020.000**\<0.01**[⁎](#tf7000){ref-type="table-fn"}0.0020.000**0.01**[⁎](#tf7000){ref-type="table-fn"}0.0010.001**0.01**[⁎](#tf7000){ref-type="table-fn"}CIS/RRMS-ON0.0010.0000.060.0010.0000.240.0010.0000.100.0010.0000.07NMOSD-ON0.0000.0000.520.0010.0000.740.0010.0000.320.0010.0000.44  Visual acuityHC0.0220.008**0.01**[⁎](#tf7000){ref-type="table-fn"}0.0190.0190.12−0.0550.019**\<0.01**[⁎](#tf7000){ref-type="table-fn"}0.0240.011**0.03**[⁎](#tf7000){ref-type="table-fn"}CIS/RRMS-NON0.0260.008**\<0.01**[⁎](#tf7000){ref-type="table-fn"}0.0410.015**0.01**[⁎](#tf7000){ref-type="table-fn"}0.0210.0270.440.0100.0170.55CIS/RRMS-ON0.0120.0110.300.0140.0170.450.0330.0240.170.0110.0190.56NMOSD-ON0.0160.0010.100.0120.0110.280.0060.0140.680.0030.0120.77[^16][^17]

### 3.2.5. RNFL and OR FA {#s0110}

Associations between RNFL and OR FA were exclusively shown in the CIS/RRMS-NON group by all methods (see [Table 8](#t0040){ref-type="table"}).

### 3.2.6. Visualy acuity and OR FA {#s0115}

Associations between visual acuity and OR FA were exclusively shown in the CIS/RRMS-NON group by JUEL-TBSS and JHU-TBSS. (see [Table 8](#t0040){ref-type="table"}).

4. Discussion {#s0120}
=============

Our study compared TBSS and probabilistic tractography based approaches to quantify OR damage in patients with NMOSD-ON and CIS with and without ON. While the distribution of absolute FA values differed among methods, correlation analyses and Bland-Altman plots revealed good agreement of FA values, especially in FA magnitudes of suspected mild OR damage, reflected by OR-specific lesion load and RNFL decrease (CIS/RRMS-ON and CIS/RRMS-NON). Both, TBSS and probabilistic tractography methods detected microstructural damage in NMOSD-ON patients compared to HCs.

4.1. Robustness of methods {#s0125}
--------------------------

CSD-PROB failed to generate OR tracts in one CIS/RRMS-ON patient, while successfully generating tracts in all other subjects. All other methods successfully identified the ORs in all subjects. It has been reported, that extensive white matter lesions in neurological disorders, such as stroke or multiple sclerosis, may lead to erroneous termination of the tracking algorithm or may cause a deviation of the bundles at the level of the lesions ([@bb0035]). A previous study in stroke patients showed that a CSD-based approach resulted in successful corticospinal tract reconstruction in 76 out of 78 tracts, while a comparative DTI-based fiber tractography resulted in the corticospinal tract reconstruction in 67 out of 78 potential tracts ([@bb0015]). For both approaches unsuccessful fiber tract reconstruction occurred in the ipsilesional hemisphere of participants, indicating lesions to be responsible for insufficient tract generation and different tractography to yield distinct susceptibilities towards lesion-associated tract generation failure ([@bb0015]). In our study, unsatisfactory tract generation in our CIS/RRMS-ON patient using CSD-PROB might be caused by extensive white matter lesions that were observed in the patient\'s optic radiations.

4.2. Inter-method comparison of FA distribution {#s0130}
-----------------------------------------------

In our study, CON-PROB showed highest coefficient of variation of FA in HC, while JUEL-TBSS showed lowest coefficient of variation. Supposing that a homogeneous and normally distributed cohort was investigated, low coefficients of variation may suggest a correlate of good method quality. High coefficients of variation in HCs in CON-PROB, possibly caused by the mainly manual approach, might impair the validity of the method. However, high coefficients may on the other hand indicate higher method sensitivity. A recently published study compared a) individual CON-PROB with b) healthy control-based CON-PROB template OR reconstructions and c) Juelich histological atlas-based OR ROI approach in 35 healthy controls and 70 MS patients ([@bb0275]). Despite differences in the reconstructed OR volumes, both OR lesion volume and OR diffusivity measurements in MS subjects were highly comparable in this study. The authors found diffusivity differences between different OR segmentation techniques to be consistently small across low and high values.

By contrast, the distribution of absolute OR FA values significantly differed in our study between nearly all methods in all patient groups and showed poor absolute agreement in the ICC analysis, except for JHU-TBSS and CSD-PROB. We conclude that differences between absolute OR FA values may impede comparisons of previous and future DTI study results investigating microstructural OR damage. The application of the exact same method is therefore necessary to allow for any statements on possible differences between OR FA values within a specific cohort of patients. These findings may be of particular significance in any case of OR DTI comparison, regardless of within-study analyses or comparisons of OR DTI results between studies, for example in meta-analyses. Comparisons of absolute OR DTI values that did not use the same post-processing approach are not valid and must therefore be avoided.

4.3. Inter-method comparison of FA correlations and agreement {#s0135}
-------------------------------------------------------------

OR FA values of all methods showed significant correlations suggesting underlying associations of FA values and actual OR specific microstructural damage regardless of method choice. Subgroup analyses of Pearson correlation coefficient analyses revealed best correlations of OR FA values in CIS/RRMS-ON and CIS/RRMS-NON. These findings are in line with a recent study reporting on good agreement between CON-PROB, template-based OR reconstruction and a Juelich OR ROI-based approach in HC and MS measured by Pearson correlation coefficents and Bland-Altman analysis ([@bb0275]).

By contrast, only limited correlations of OR FA values were seen in our study in the non-damage group (HC) and patients with suspected extensive OR damage (NMOSD-ON).

In a recent study, CSD-PROB was investigated in ten HCs and five MS patients to compare tractography results with histological masks. It showed a good sensitivity ranging from 65% to 81% and a specificity up to 100% ([@bb0125]). Another recent study compared CSD-PROB with Juelich histological atlas in 20 patients with various neurological conditions, showing a good match of the probabilistic tractography approach with a mean AUC of 0.87 ([@bb0120]). These findings are in line with our study showing relatively little bias between JUEL-TBSS masking approach and CSD-PROB in the conducted Bland-Altman analysis. Bland-Altman analysis revealed best agreement between all methods at medium FA values (0.45--0.5) suggesting good agreement of methods in identifying damage of medium magnitude (CIS/RRMS-ON and CIS/RRMS-NON). These findings might -- at least to a certain extent -- suggest the convertibility of results by different DTI post-processing methods when applied to patient groups with OR damage of mild to moderate magnitude. Concrete research approaches to patient groups with suspected mild OR damage, for example CIS patients, could be sufficiently tackled by all investigated methods, while investigations regarding HCs or severely affected patient groups (NMOSD-ON) might lead to different results, highly dependent of the chosen method.

The presence of systematic bias and proportional errors in the comparison of DTI TBSS-based and tractography based methods may lead to false positive or false negative results when different patient groups are compared by different methods. While one method might produce significant differences in group comparison due to underestimation of low FA values, another method may yield non-significant results due to relative overestimation of low FA values. These findings might be a causative factor of today\'s equivocal findings ([@bb0010]) of previous DTI visual pathway analyses that impede the evaluation of DTI as a potential biomarker ([@bb0075]).

4.4. NMOSD vs. HC group comparison {#s0140}
----------------------------------

Group comparison showed FA differences between NMOSD-ON and HCs throughout all TBSS and probabilistic tractography based methods. Best effect size and AUC values to distinguish both groups were observed for CSD-PROB. JHU-TBSS, JUEL-TBSS and CON-PROB showed slightly lower AUC values and effect size. Our study results are in line with previous investigations using DTI reporting on microstructural degradation with significant FA reduction within the OR ([@bb0140]; [@bb0145], [@bb0150]; [@bb0185]; [@bb0295]). A previous study in NMOSD patients, using TBSS, found FA values to be exclusively reduced in regions associated to the visual system by making use of a TBSS ROI and a multivariate comparison approach. These results provide evidence of anterograde trans-synaptic degeneration due to ON ([@bb0145], [@bb0150]). By contrast, one TBSS-based study demonstrated reduced FA involving not only the OR but also diffuse subcortical white matter structures in frontal, parietal, temporal, occipital and limbic regions ([@bb0265]). Another study used CSD-PROB OR tractography and revealed FA reductions within the OR of 25 AQP4-antibody seropositive NMOSD patients ([@bb0140]). Notably, OR FA was not only reduced in NMOSD patients with previous ON but FA reductions were also detectable in 6 NMOSD patients with longitudinally extensive transverse myelitis (LETM) without evidence of prior ON. These results were corroborated by another study that used FSL-based probabilistic tractography (FSL\'s probtrackx) to delineate the OR and found FA reduction within the OR of 24 NMOSD patients with prior ON (58.3% AQP4-antibody seropositive) as well as in 12 NMOSD patients without prior ON (66.6% AQP4-antibody positive) ([@bb0240]). These findings suggest microstructural changes in the afferent visual system independent of ON attack-related mechanisms.

Although clinical history of our NMOSD patients with prior unilateral or bilateral ON, long disease duration and pronounced visual impairment and OCT RNFL thinning suggests the presence of attack-related optic radiation FA decrease in our NMOSD cohort, we did not find any direct associations between OCT RNFL or visual acuity and optic radation FA, irrespective of the method. However, our data mirror the clinical experience as well as findings from conventional imaging studies showing that neurological disability and tissue damage in the visual pathway are on average more pronounced in NMOSD as compared to MS/CIS, as it can be seen in the relatively frequent bilateral manifestation of optic neuritis in our NMOSD-cohort compared to CIS/RRMS-ON ([@bb0030]; [@bb0095]; [@bb0195]).

4.5. CIS/RRMS-ON and CIS/RRMS-NON vs. HC {#s0145}
----------------------------------------

No difference of OR FA between CIS/RRMS-ON and HC was seen in any of the methods used. CSD-PROB showed differences between HC and CIS/RRMS-NON. In CIS and early stages of MS, OR microstructural damage is most likely caused by 1) trans-synaptic neurodegeneration after ON ([@bb0055]) and 2) impact of T2 inflammatory lesions within the OR ([@bb0060]; [@bb0210], [@bb0215]).

Damage in the OR of ON patients due to inflammatory T2 lesions has been investigated previously. Raz et al. reported on reduced OR FA by making use of CON-PROB in patients with clinically isolated ON compared to healthy controls. In this study, reduced OR FA was associated with OR specific T2 lesion volume suggesting FA differences to be explained by intrabundle lesions ([@bb0170]). In our CIS/RRMS-NON cohort, OR FA in JUEL-TBSS, JHU-TBSS and CSD-PROB was associated with OR specific T2 lesion volume, indicating TBSS approaches to be more sensitive to lesional damage than probabilistic tractography approaches. These findings indicate lesional damage to be at least partly responsible for damage within the ORs of CIS/RRMS patients without prior ON. However, recent findings indicated the presence of a measurable, time-dependent trans-synaptic neurodegeneration effect on the OR after ON, independent of T2 lesion load. Longitudinal investigations using an atlas-based OR template ROI in 38 acute ON patients over 12 months showed FA reduction at baseline and subsequent additional FA decrease at an average rate of −2.6% per year ([@bb0110]). Another study investigated twenty-eight acute ON patients by use of the FSL based probabilistic tractography algorithm and found no difference between patients\' and controls\' mean OR FA at baseline but a constant decrease over time after 3, 6 and 12 months ([@bb0260]). No associations between RNFL and OR FA were found in CIS/RRMS-ON patients. Given the relatively short time after ON in our CIS/RRMS-ON cohort with a mean disease duration of 4.63 ± 5.15 months after ON, we presume that the early timepoint of MRI acquisition after ON makes the determination of any trans-synaptic effect on the optic radiations unlikely.

4.6. Tract profiling using probabilistic tractography methods {#s0150}
-------------------------------------------------------------

Tract-profiling group differences between HC and NMOSD were seen in higher proportion of nodes in CON-PROB compared to CSD-PROB, indicating CON-PROB tract-profiling to yield higher sensitivity for the detection of microstructural OR damage in NMOSD compared to CSD-PROB tract profiling. Using CON-PROB, tract-profiling enabled the distinction between OR fibers affected by T2 lesions and non-lesional OR fibers. Radial diffusivity, mean diffusivity and FA changes were detected along the entire OR, while axial diffusivity changes were confined to the posterior half of the OR. This discrepancy implied distinct pathophysiologic processes to be detectable by DTI tract profiling ([@bb0105]).

In our study, tract profiling showed middle and posterior parts of the OR to be more affected than anterior OR sections in NMOSD compared to HC. These findings may suggest distinct regions of the OR to exhibit more pronounced damage by trans-synaptic neurodegeneration or distinct OR T2 lesional damage affecting only specific regions of the OR due to Wallerian degeneration ([@bb0105]). However, in our analysis overall NMOSD OR FA was not associated with optic radiation T2 lesion volume. Distinct regions of the OR are supposed to be less affected by contamination from craniocaudally oriented crossing fibers to the optic radiation. Neighbouring and crossing white matter pathways may additionally lead to a reduced FA in OR fiber regions ([@bb0090]). Exclusive microstructural OR damage is more likely to be observable by DTI in regions that are not affected by crossing or kissing fibers, which are represented by distinct middle and posterior parts of the OR. Both, the affection of the OR by crossing and kissing fibers, as well as distinct damage patterns caused by the localization of OR-specific T2 lesions or trans-synaptic neurodegeneration damage patterns may therefore be the cause of different levels in FA decrease along OR regions.

4.7. Technical aspects {#s0155}
----------------------

TBSS can be implemented fully-automated requiring no manual intervention. In TBSS, the average FA may be affected by surrounding structures due to partial voluming ([@bb0230]). Probabilistic tractography is more time-consuming due to manual and calculation processes inherent to the specific algorithm ([@bb0275]). Tractography algorithms are known to be - at least to a certain extent - susceptible to image artifacts with possible insufficient tract generation ([@bb0015]). However, the CSD-PROB approach used in our study represents a feasible and fully-automated probabilistic tractography method, requiring no manual intervention compared to previously used CON-PROB ([@bb0275]).

4.8. Limitations {#s0160}
----------------

Given the multitude of methods that exist for tractography and the comparison of DWI measures, our study naturally fails to comprehensively include all alternative methods for comparison. Our study is limited by the small sample size of the respective subpopulations mitigating validity of our cross-method comparison.

5. Conclusion {#s0165}
=============

To our knowledge, this is the first study to compare multiple probabilistic tractography and TBSS-based approaches to quantify microstructural OR damage in patients with neuroinflammatory visual pathway damage. We proved TBSS-based and probabilistic tractography based DWI processing techniques to be feasible in detecting microstructural damage within the OR. Absolute FA values differed between the methods, preventing comparisons of OR FA analyses of previous and future studies with different post-processing approaches. Correlation and agreement of all methods\' FA values were best in patients with suggested mild to moderate OR FA damage (CIS/RRMS patients), indicating methods to be exchangeable -- at least to a certain extent -- in the analysis of CIS/RRMS patients but not if healthy controls or patients with suspected severe damage (NMOSD-ON) are investigated. Due to systematic bias and proportional errors of FA between methods, the comparison of subject groups by use of different methods leads to different (either false-positive or false-negative) results. Although the pattern of differences between the patient cohorts was similar in our study, CSD-PROB showed significant FA differences between HC and CIS/RRMS-NON patients. Although these CSD-PROB derived differences between the groups could result from the above-mentioned systematic bias, we suggest CSD-PROB to be more sensitive to early neuroinflammatory damage, partially associated with lesions. All methods were successful in differentiating NMOSD-ON patients from HCs. Given that CSD-PROB showed highest AUC and effect size followed by JHU-TBSS, JUEL-TBSS and CON-PROB, CSD-PROB approach might be the method of choice to further investigate differential diagnostic aspects between HC and NMOSD. Tract-profiling differences between HC and NMOSD were more pronounced in CON-PROB, which might be the method of choice for tract profiling assessments. In our study, TBSS-based approaches showed better correlations with OR specific lesions, which could favor them as the method of choice for future studies to investigate the relationship between T2 lesions and DTI. Given the lack of a "gold-standard" for non-invasive DW-MRI OR delineation ([@bb0115]; [@bb0120]; [@bb0235]), future studies are required to fully validate the capacity and limitations of different post-processing methods with regards not only to differential diagnosis and T2 lesional impact on DTI, but also concerning longitudinal FA assessment and OR DTI relationships with visual function.

The following are the supplementary data related to this article.Fig. S1Image processing pipelines.**A** and **B**: JUEL-TBSS and JHU-TBSS - Using (A1 and B1) raw DW imaging data, (A2 and B2) FA maps were created by fitting a tensor model. After (A3 and B3) brain-extraction a mean FA image was created and thinned to produce a mean FA skeleton. (A4 and B4) Each subject\'s aligned FA data was then projected onto this skeleton. Either (A5) Juelich probabilistic atlas ROI with FA skeleton mask was applied (JUEL-TBSS) and (A6) thresholded, excluding the lower 10%, or (B5) JHU posterior thalamic radiation atlas ROI combined with FA skeleton mask was applied on each subject\'s aligned FA data (B6) to generate the mean FA.**C**: CON-PROB - (C1) Raw DW imaging data were used to calculate (C2) FA maps within vistalab environment. (C3) LGN ROI was placed manually and (C4) optic radiation was calculated using Contrack algorithm. (C5) Resulting fibers were used to compute tract profiling diffusion properties.**D**: CSD-PROB - Maps of fiber orientation distribution (D1) were calculated using CSD from DW image. (D2) Juelich atlas based LGN and V1 ROI were used as seed mask and target masks. Additionally, sagittal, coronal and grey matter exclusion ROIs were registered from MNI152 to registered from atlas to individual DWI space. (D3) A set of 10.000 streamlines was generated and a threshold of 25% of the maximum value was applied. Resulting fibers were (D4) transferred to Vistalab environment to (D5) compute tract profiling diffusion properties.Fig. S1Fig. S2Absolute FA values of different DTI post-processing methods within each subject group.FA values of left and right optic radiation are shown for separately for Optic radiation FA values are shown for **A** and **B** healthy controls (HC), **C** and **D** CIS/RRMS patients without prior optic neuritis, **E** and **F** CIS/RRMS patients with optic neuritis in their medical history and **G** and **H** NMOSD-ON patients.JUEL-TBSS = Juelich-based atlas ROI TBSS approach; JHU-TBSS = Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB = ConTrack-based probabilistic tractography. CSD-PROB = constrained spherical deconvolution based probabilistic tractography. TBSS = tract-based spatial statistics.Fig. S2Fig. S3Correlation of FA values of each method by subject group.Correlation of OR FA values of every method (JUEL-TBSS vs. JHU-TBSS; JUEL-TBSS vs. CON-PROB; JUEL-TBSS vs. CSD-PROB; JHU-TBSS vs. CON-PROB; JHU-TBSS vs. CSD-PROB; CON-PROB vs. CSD-PROB) by subject groups HC (**A**--**F**), CIS/RRMS-NON (**G**--**L**), CIS/RRMS-ON (**M**--**R**), and NMOSD-ON (**S**--**X**).JUEL-TBSS = Juelich-based atlas ROI TBSS approach; JHU-TBSS = Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB = ConTrack-based probabilistic tractography. CSD-PROB = constrained spherical deconvolution based probabilistic tractography. TBSS = tract-based spatial statistics; OR = optic radiation; HC = healthy controls; CIS/RRMS-NON = CIS patients with no prior optic neuritis; CIS/RRMS-ON = CIS patients with prior optic neuritis; NMOSD-ON = Neuromyelitis optica spectrum disorder patients with prior optic neuritis.Fig. S3Fig. S4Bland-Altman analysis of mean FA values comparing all methods.Bland-Altman analysis of individual FA values from all subjects including both left and right OR. Middle lines indicate mean differences and dashed lines are limits of agreement. **A** JUEL-TBSS and JHU-TBSS OR ROI masking; **B** TBSS-JHU and CSD-PROB; **C** JHU-TBSS and CON-PROB; **D** JUEL-TBSS and CSD-PROB; **E** JUEL-TBSS and CON-PROB; **F** CSD-PROB and CON-PROB.JUEL-TBSS = Juelich-based atlas ROI TBSS approach; JHU-TBSS = Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB = ConTrack-based probabilistic tractography. CSD-PROB = constrained spherical deconvolution based probabilistic tractography. TBSS = tract-based spatial statistics; OR = optic radiation.Fig. S4Supplementary materialImage 1
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[^4]: HC = healthy control; CIS/RRMS-NON = clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON = clinically isolated syndrome with prior optic neuritis; NMOSD-ON = neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^5]: p \< 0.05.

[^6]: ICC analysis of all 4 methods (JUEL-TBSS, JHU-TBSS, CON-PROB and CSD-PROB).

[^7]: HC = healthy control; CIS/RRMS-NON = clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON = clinically isolated syndrome with prior optic neuritis; NMOSD-ON = neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^8]: p \< 0.05.

[^9]: SD = standard deviation; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^10]: HC = healthy control; CIS/RRMS-NON = clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON = clinically isolated syndrome with prior optic neuritis; NMOSD-ON = neuromyelitis optica spectrum disorder with prior optic neuritis; FA = fractional anisotropy; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^11]: Exploratory ANOVA and subsequent *t*-test p-values.

[^12]: p \< 0.05 (significant from HC).

[^13]: HC = healthy control; CIS/RRMS-NON = clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON = clinically isolated syndrome with prior optic neuritis; NMOSD-ON = neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^14]: p \< 0.05.

[^15]: HC = healthy control; CIS/RRMS-NON = clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON = clinically isolated syndrome with prior optic neuritis; NMOSD-ON = neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography.

[^16]: JUEL-TBSS = Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS = Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB = Contrack-based probabilistic tractography; CSD-PROB = constrained spherical deconvolution based probabilistic tractography. RNFL = retinal nerve fiber layer thickness. Significant p-values are displayed in bold.

[^17]: p \< 0.05.
